NEW YORK (GenomeWeb News) – Two hospitals in the Netherlands — the University Medical Center Groningen and Amphia Hospital — plan to evaluate and adopt Pathogenica's next-generation sequencing-based HAI BioDetection Kit in the surveillance and monitoring of infectious bacteria, the company said today.

Pathogenica's kit uses molecular inversion probe technology and targeted sequencing to enable the identification and subtyping of the 12 bacterial species that are responsible for more than 95 percent of hospital-acquired infections.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.